Substituted furo[2,3-b]pyridine derivatives as Cannabinoid-1 receptor modulators
Details for Australian Patent Application No. 2008239755 (hide)
International Classifications
Event Publications
29 October 2009 PCT application entered the National Phase
PCT publication WO2008/127585 Priority application(s): WO2008/127585
12 November 2009 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the name Merck & Co., Inc., Application No. 2008239755, under INID (54) correct the title to read Substituted furo[2,3-beta]pyridine derivatives as Cannabinoid-1 receptor modulators Corrigenda
21 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008239795-Novel strategies for delivery of active agents using micelles and particles
2008239754-CGRP receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser